Pub. Date : 2021
PMID : 34262462
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | By binding to the BCR-ABL1 kinase and inhibition of downstream target phosphorylation, TKIs, such as imatinib or nilotinib, can be used as single agents to treat CML patients resulting in 80 % 10-year survival rates. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |